{
	"name": "common assay template",
	"descr": "The Common Assay Template is designed to capture most of the high value data from in vitro assays, particularly those used for high throughput screening.",
	"schemaURI": "http://www.bioassayontology.org/bas#",
	"assignments": 
	[
		{
			"name": "bioassay type",
			"descr": "Categorization of bioassays based on the property or process that the assay is interrogating, e.g. ADMET, functional, etc.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002854",
			"locator": "0",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "bioassay",
			"descr": "Categorization of the general class of bioassay (enyzme activity, gene expression...)",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002855",
			"locator": "1",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "assay format",
			"descr": "Assay format is a conceptualization of assays based on the biological and / or chemical features of the experimental system. For example assay formats include biochemical assays - referring to assays with purified protein, cell-based - referring to assays in whole cells, or organism-based - referring to assays performed in an organism.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0000205",
			"locator": "2",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "assay design method",
			"descr": "The assay design method describes how a biological or physical process screened / investigated in the model system is translated into a detectable signal. This relates to the technology / technologies used to make the assay system work, i.e. enable that the screened process can be detected.  It typically involves some manipulation of the (biological) model system to detect the process of interest.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0095009",
			"locator": "3",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "assay supporting method",
			"descr": "Assay supporting methods describe the methods to prepare, generate or post-process the assay system or assay screening process. Such methods include the sample preparation, labeling, data processing, etc., which are required to performing the assay, but do not constitute the actual assay (design method).",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0095010",
			"locator": "4",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "assay cell line",
			"descr": "An assay cell line refers to the source of the cells or cell line used in the assay. This may be from primary cells (as annotated) or, more frequently, from an immortal cell line. Due to the continued passaging of immortal cell lines, users must be aware that spontaneous mutations can, and often do, arise in sub-populations, such that the actual cells used in the individual assay may differ from the original source.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002800",
			"locator": "5",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "organism",
			"descr": "The organism related to the target / meta-target of the bioassay. It includes both bacterium and eukaryote.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002921",
			"locator": "6",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "biological process",
			"descr": "Any process specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end (from GO). For annotated BioAssays, Biological Process is the process that is being (or is presumed to be) affected by an entity with a perturbagen role in the assay.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002009",
			"locator": "7",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "target",
			"descr": "The molecular entity (e.g., protein, carbohydrate, nucleic acid, or other) that is the presumed subject of the assay and whose activity is being effected by an entity with a perturbagen role in the assay. Can encompass the TYPE of biological macromolecule (e.g., enzyme, chaperone, GPCR, etc.) as well as the specific molecular target (e.g., gene name or geneid). An assay can have zero (e.g., if unknown as in assays for cytotoxic compounds) or multiple targets.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0000211",
			"locator": "8",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "applies to disease",
			"descr": "Disease targets that the assay is designed to affect. This is a more general term than the specific biological target.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002848",
			"locator": "9",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "assay mode of action",
			"descr": "Assay mode of action refers both to the mechanism (binding vs. functional) and the effect of the perturbagen on the target - whether it brings about inhibition, activation, cytotoxicity, etc.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0000196",
			"locator": "10",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "result",
			"descr": "The endpoint is a quantitive or qualitative interpretable standardized representation of a perturbation (a change from a defined reference state of a \"closed\" model system) that is measured by the bioassay.  An endpoint consists of a series of data points, one for each perturbing agent (screened entity) tested the assay.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0000208",
			"locator": "11",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "screening campaign stage",
			"descr": "The assay stage describes the purpose of the assay in an assay campaign.  Assay stage also relates to the order of assays in a screening campaign.  For example the primary assay, which is performed first, identifies hits. The primary hits are then confirmed in a confirmatory assay.  Subsequent secondary assays are run to eliminate compounds that are not of interest or to confirm hits using an alternate design / technology, or to further characterize compounds.\nWhether an assay is run in single concentration or concentration response is defined in the class 'assay measurement throughput quality'.  For example primary assays are typically run in single concentration with single measurements. However, the NCGC runs qHTS primary assays as concentration-response assays.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0000210",
			"locator": "12",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "assay footprint",
			"descr": "This describes the physical format such as plate density in which an assay is performed, which is generally a microplate format, but can also be an array format.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002867",
			"locator": "13",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "assay kit",
			"descr": "The title of the kit/biologicals used in the assay.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002663",
			"locator": "14",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "physical detection method",
			"descr": "The physical method (technology) used to measure / readout the effect caused by a perturbagen in the assay environment.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0000207",
			"locator": "15",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "detection instrument",
			"descr": "The names of equipment used for measurement/readout from an assay, e.g. FLIPR, ViewLux plate reader, PHERAstar, etc.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002865",
			"locator": "16",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "perturbagen type",
			"descr": "Compounds or other perturbagens that modulate diverse biological targets.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0000185",
			"locator": "17",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "protein identity",
			"descr": "Protein identity, from the NCBI reference set.",
			"propURI": "http://www.bioassayontology.org/bao#BAX_0000012",
			"locator": "18",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "gene identity",
			"descr": "Gene identity, from the NCBI reference set.",
			"propURI": "http://www.bioassayontology.org/bao#BAX_0000011",
			"locator": "19",
			"suggestions": "full",
			"groupNest": 
			[
			]
		},
		{
			"name": "GO terms",
			"descr": "Functions of the target gene, selected from the Gene Ontology hierarchy.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0003107",
			"locator": "20",
			"suggestions": "disabled",
			"groupNest": 
			[
			]
		},
		{
			"name": "field",
			"descr": "Field name for the column that supplies the activity units.",
			"propURI": "http://www.bioassayontology.org/bao#BAX_0000015",
			"locator": "0:0",
			"suggestions": "field",
			"groupNest": 
			[
				"http://www.bioassayontology.org/bao#BAX_0000017"
			]
		},
		{
			"name": "units",
			"descr": "Units for the resulting measurements (e.g. IC50, EC50, etc.)",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002874",
			"locator": "0:1",
			"suggestions": "full",
			"groupNest": 
			[
				"http://www.bioassayontology.org/bao#BAX_0000017"
			]
		},
		{
			"name": "operator",
			"descr": "Defines the cutoff relationship for active/inactive",
			"propURI": "http://www.bioassayontology.org/bao#BAX_0000016",
			"locator": "0:2",
			"suggestions": "full",
			"groupNest": 
			[
				"http://www.bioassayontology.org/bao#BAX_0000017"
			]
		},
		{
			"name": "threshold",
			"descr": "Defines the value cutoff for active/inactive.",
			"propURI": "http://www.bioassayontology.org/bao#BAO_0002916",
			"locator": "0:3",
			"suggestions": "number",
			"groupNest": 
			[
				"http://www.bioassayontology.org/bao#BAX_0000017"
			]
		}
	],
	"groups": 
	[
		{
			"name": "common assay template",
			"descr": "The Common Assay Template is designed to capture most of the high value data from in vitro assays, particularly those used for high throughput screening.",
			"locator": "",
			"groupURI": ""
		},
		{
			"name": "measurement",
			"descr": "Compound activity measurements: which field defines activity and how so.",
			"locator": "0:",
			"groupURI": "http://www.bioassayontology.org/bao#BAX_0000017"
		}
	]
}
